Literature DB >> 9638441

Isoflurane hepatotoxicity in a patient with a previous history of halothane-induced hepatitis.

F Hasan1.   

Abstract

Halogenated volatile anesthetics have been associated with liver injury. Most reported cases have been linked to halothane and enflurane. Cross-sensitization between the latter agents has also been documented. Isoflurane hepatitis is extremely rare, and only a few convincing cases have been published. Moreover, clinical cases of cross-sensitization of isoflurance with other haloalkanes have not been reported. We describe a case of hepatic dysfunction 2 weeks after isoflurance anesthesia in a 35-year-old obese woman with a previous history of halothane hepatitis. The diagnosis was made on the basis of exposure to isoflurance, the delay between the time of exposure and the onset of jaundice, and the exclusion of other causes of liver dysfunction. This case reiterates the recommendation that patients who sustain liver injury from one haloalkane should not be exposed to another.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9638441

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

Review 1.  [New technical developments for inhaled sedation].

Authors:  A Meiser; H Bomberg; T Volk; H V Groesdonk
Journal:  Anaesthesist       Date:  2017-04       Impact factor: 1.041

Review 2.  Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review.

Authors:  L Delgado-Herrera; R D Ostroff; S A Rogers
Journal:  CNS Drug Rev       Date:  2001

3.  [Fulminant hepatic failure after simultaneous kidney-pancreas transplantation: a case report].

Authors:  Jimmy L Moss; Benjamin W Brown; Sher-Lu Pai; Klaus D Torp; Stephen Aniskevich
Journal:  Braz J Anesthesiol       Date:  2018-06-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.